title: Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
abstract: Wnt signaling plays a crucial role in a number of developmental processes and in tumorigenesis. beta-Catenin is stabilized by Wnt signaling and associates with the TCF/LEF family of transcription factors, thereby activating transcription of Wnt target genes. Constitutive activation of beta-catenin-TCF-mediated transcription resulting from mutations in adenomatous polyposis coli (APC), beta-catenin, or Axin is believed to be a critical step in tumorigenesis among divergent types of cancers. Here we show that the transactivation potential of the beta-catenin-TCF complex is enhanced by its interaction with a BCL9-like protein, B9L, in addition to BCL9. We found that B9L is required for enhanced beta-catenin-TCF-mediated transcription in colorectal tumor cells and for beta-catenin-induced transformation of RK3E cells. Furthermore, expression of B9L was aberrantly elevated in about 43% of colorectal tumors, relative to the corresponding noncancerous tissues. These results suggest that B9L plays an important role in tumorigenesis induced by aberrant activation of Wnt signaling.
authors.affiliation: Institute for Molecular and Cellular Biosciences and Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
authors.forename: Shungo
authors.initials: S
authors.lastname: Adachi
authors.forename: Takafumi
authors.initials: T
authors.lastname: Jigami
authors.forename: Toshio
authors.initials: T
authors.lastname: Yasui
authors.forename: Tetsuhiro
authors.initials: T
authors.lastname: Nakano
authors.forename: Susumu
authors.initials: S
authors.lastname: Ohwada
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Omori
authors.forename: Sumio
authors.initials: S
authors.lastname: Sugano
authors.forename: Bisei
authors.initials: B
authors.lastname: Ohkawara
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shibuya
authors.forename: Tsutomu
authors.initials: T
authors.lastname: Nakamura
authors.forename: Tetsu
authors.initials: T
authors.lastname: Akiyama
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D002471:Cell Transformation, Neoplastic; D015179:Colorectal Neoplasms / Q000235:genetics / Q000378:metabolism; D003598:Cytoskeletal Proteins / Q000378:metabolism* / Q000502:physiology; D004268:DNA-Binding Proteins / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry; D036341:Intercellular Signaling Peptides and Proteins / Q000502:physiology*; D051821:Lymphoid Enhancer-Binding Factor 1; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins; D011485:Protein Binding; D051381:Rats; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015398:Signal Transduction / Q000502:physiology; D015534:Trans-Activators / Q000378:metabolism* / Q000502:physiology; D014157:Transcription Factors / Q000235:genetics / Q000378:metabolism / Q000502:physiology*; D014158:Transcription, Genetic; D014162:Transfection; D051153:Wnt Proteins; D051176:beta Catenin
chemical_list: C495498:BCL9L protein, human; C501227:Bcl9l protein, rat; C495270:CTNNB1 protein, human; C495268:Ctnnb1 protein, rat; D003598:Cytoskeletal Proteins; D004268:DNA-Binding Proteins; D036341:Intercellular Signaling Peptides and Proteins; D051821:Lymphoid Enhancer-Binding Factor 1; D009363:Neoplasm Proteins; D015534:Trans-Activators; D014157:Transcription Factors; D051153:Wnt Proteins; D051176:beta Catenin